News

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap
Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...
MONTCO Today on MSN12h
WSJ: Merck Makes $10 Billion Move as Keytruda Patent Expiration Nears
Merck is making big pharma waves again with a $10 billion deal to acquire Verona Pharma, reports Colin Kellaher for the Wall ...
Brothers from India sentenced in Seattle for selling fake, contaminated medicine to U.S. patients
Two brothers from India were each sentenced to 30 months in prison for a scheme to sell counterfeit and adulterated drugs in ...
Merck Buys Verona Pharma: A Good Deal, But M&A Spree Must Continue
Merck & Co., Inc. is acquiring Verona Pharma plc for $10bn to bolster long-term growth with COPD drug Ohtuvayre. Click for my ...
Major deals involving U.S. drugmakers and biotechs over the past decade
Merck is acquiring UK-based Verona Pharma for about $10 billion, as part of the U.S. drugmaker's strategy to diversify beyond ...
Hoodline1d
Indian Nationals Sentenced to 30 Months for Smuggling Counterfeit Cancer Drugs into U.S.
Two Indian nationals were sentenced to 30 months in prison for smuggling counterfeit cancer drugs into the US.
Brothers sentenced to prison for smuggling fake and contaminated drugs
Two brothers from India were sentenced to 30 months in prison after they were found guilty of trying to sell counterfeit, ...
Kazia Reports Over 50% Cancer Cell Reduction In Early Data From Breast Cancer Trial, Stock Jumps
Kazia Therapeutics (NASDAQ:KZIA) on Wednesday reported preliminary results from the first patient in its Phase 1b trial ...
Zacks Investment Research on MSN1d
Merck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock?
Merck MRK announced a definitive agreement to acquire Verona Pharma VRNA for approximately $10 billion. The deal will add ...